Butorphanol Tartrate 00409-1626-02
- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- December 20, 2005
- Listing Expires
- December 31, 2027
- Application
- ANDA074626
Active Ingredients
| Ingredient | Strength |
|---|---|
| Butorphanol Tartrate | 2 mg/mL |
Drug Class
Competitive Opioid Antagonists [MoA]Opioid Agonist/Antagonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
00409-1626-02Selected10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-02) / 2 mL in 1 VIAL, SINGLE-DOSE (0409-1626-42)
Other packages for this product(1)
10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1626-01) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-1626-21)